Abstract OT-28-03: VICKI: A Phase Ib/II, Randomized, Placebo-Controlled, Study of Venetoclax Plus Ado-Trastuzumab Emtansine (T-DM1) in Patients (pts) with Previously Treated HER2-positive Locally Advanced (LA) or Metastatic Breast Cancer (MBC)
Cancer Research（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要